Toxoplasmosis in immunosuppressed patients. Contribution to the knowledge of toxoplasmic infection;Toxoplasmose chez les patients immunodéprimés. Apport à la connaissance de l'infection toxoplasmique

Medecine et Maladies Infectieuses

Volumn 26, Issue 3, 1996, Pages 437-440

  Leport, C ^a   Derouin, F ^b   Morlat, P ^c   Chene, G ^d   Vilde J L ^a  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

^d INSERM   (France)

Author keywords

HIV infection; Immunodeficiency; Prevention; Reactivation; Toxoplasmosis

Indexed keywords

COTRIMOXAZOLE; FANSIDAR; PYRIMETHAMINE; SULFAMETHOXAZOLE;

ADULT; CONFERENCE PAPER; FRANCE; GOOD CLINICAL PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MEDICAL INFORMATION; TOXOPLASMOSIS;

EID: 0029886881     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-077x(96)80189-2     Document Type: Article

References (32)

1. HOWE K.D., SIBLEY L.D. - Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995; 172: 1561-6.
2. SUZUKI Y., WONG S.-Y., GRUMET F.C., FESSEL J., MONTOYA J.G, ZOLOPA A.R., PORTMORE A., SCHUMACHER-PERDREAU F., SCHRAPPE M., KOPPEN S., RUF B., BROWN B.W., REMINGTON J. - Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis. 1996; 173: 265-8.
3. JOHNSON L.L., GIBSON G.W., SAYLES P.C.- Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice. Exp Parasitol. 1995; 81: 172-81.
4. ODAERT H., SOETE M., FORTIER B., CAMUS D., DUBREMETZ J.F. - Stage conversion of Toxoplasma gondii in mouse brain during infection and immunodepression. Parasitol Res. 1996; 82: 28-31.
5. DEROUIN F., DEVERGIE A., AUBER P., GLUCKMAN E., BEAUVAIS B., GARIN Y.J.F., LARIVIERE M. - Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis. 1992; 15: 267-70.
6. O'DRISCOLL J.C., HOLLIMAN R.E. - Toxoplasmosis and bone marrow transplantation. Rev Med Microbiol. 1991; 2: 215-22.
7. SLAVIN M.A., MEYERS J.D., REMINGTON J.S., HACKMAN R.C. - Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant. 1994; 13: 549-57.
8. FOOT A.B.M., GARIN Y.J.F., RIBAUD P., DEVERGIE A., DEROUIN F. GLUCKMAN E. - Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant. 1994: 14: 241-5.
9. LUFT B.J., NAOT Y., ARAUJO F.G., STINSON E.B., REMINGTON J.S. - Primary and reactivated toxoplasma infection in patients with cardiac transplants. Ann Intern Med. 1983; 99: 27-31.
10. DEROUIN F., DEBURE A., GODEAULT E., LARIVIERE M., KREIS H. - Toxoplasma antibody titers in renal transplant recipients. Transplantation. 1987; 44: 515-8.
11. LAVARDE V., HEYER F., GUILLEMAIN R., AMREIN C., VULSER C., DREYFUS G. - Toxoplasmose et transplantation cardiaque. Intérêt et limite de la sérologie. Méd Mal Infect. 1990; 20: 121-5.
12. BOUREE P., ROMAND S., MAJOUBE A. - Toxoplasmose et transplantation hépatique: surveillance de 34 patients par deux techniques sérologiques. Bull Soc Fr Parasitol. 1995; 13: 155-60.
13. HAKIM M., ESMORE D., WALLWORK J., ENGLISH T.A.H., WREGHITT T. - Toxoplasmosis in cardiac transplantation. Brit Med J. 1986; 292: 1108.
14. SPEIRS G.E., HAKIM M., CALNE R.Y., WREGHITT T.G. - Relative risk of donor-transmitted Toxoplasma gondii infection in heart, liver and kidney transplant recipients. Clin Transplant. 1988; 2: 257-60.
15. ORR K.E., GOULD F.K., SHORT G., DARK J.H., HILTON C.J., CORRIS P.A., FREEMAN R. - Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect. 1994; 29: 249-53.
16. MICHAELS M.G., WALD E.R., FRICKER F.J., DEL NIDO P.J., ARMITAGE J. - Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis. 1992; 14: 847-51.
17. WREGHITT T.G., HAKIM M. GRAY J.J., BALFOUR A.H., ISTOVIN G.P., STEWART S., SCOTT J., ENGLISH T.A.H., WALLWORK J. - Toxoplasmosis in heart and heart and lung transplant recipient. J Clin Pathol. 1989; 42: 194-9.
18. RENOULT E., CHABOT F., AYMARD B., HESTIN D., DELORME N., BIAVA M.F., KURES L., KESSLER M.- Generalized toxoplasmosid in two renal transplant recipients who received a kidney from the same donor. Rev Infect Dis. 1991; 13: 180-1.
19. ROSTAING L., BARON E., FILLOLA O., ROQUES C., DURAND D., MASSIF P., LLOVERAS J.J., SUC J.M. - Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration. Transplant Proc. 1995; 27: 1733-4.
20. ISRAELSKI D.M., REMINGTON J.S. - Toxoplasmosis in patients with cancer. Clin Infect Dis. 1993; 17 (Suppl): S423-35.
21. RUSKIN J., REMINGTON J.S. - Toxoplasmosis in the compromised host. Ann Intern Med. 1976; 84: 193-9.
22. LUFT B.J., REMINGTON J.S. - Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992; 15: 211-22.
23. ROUSSEAU F., LEPORT C., VILDE J.-L. - Prévention de la toxoplasmose chez les immunodéprimés. Méd Mal Infect. 1993; 23 Spécial: 201-10.
24. GRANT I.H, GOLD J.W.M., ROSENBLUM M., NIEDZWIECKI D., AMSTRONG D. - Toxoplasma gondii serology in HIV infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990; 4: 519-21.
25. LEPORT C., CHENE G., MORLAT P., LUFT B., ROUSSEAU F., PUYEO S., HAFNER R., MIRON J., AUBERTIN J., SALAMON R., VILDE J.L. - Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunofeciency virus infection: a double blind randomized trial. J Infect Dis. 1996; 173: 91-7.
26. OKSENHENDLER E., CHARREAU I, TOURNERIE C., AZIHARY M., CARBON C., ABOULKER J.P. - Toxoplasma gondii in advanced HIV infection. AIDS. 1994; 8: 483-7.
27. DEROUIN F., PUEYO S., MORLAT P., LETRILLARD B., LEPORT C., CHENE G., ECOBICHON J.-L., LUFT B., AUBERTIN J., HAFNER R., VILDE J.-L., SALAMON R. - Predictive value of Toxoplasma gondii IgG antibody titer on the occurrence of cerebral toxoplasmosis in HIV-infected patients. Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995, abstract I36.
28. LUCET J.C., BAILLY M.P., BEDOS J.P., WOLFF M., GACHOT B., VACHON F. - Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus. Chest. 1993; 104: 1054-8.
29. RAFFI F., TIAB M., MORIN O. DEROUIN F. - Toxoplasmose cérébrale au cours du SIDA, manifestation de la primoinfection toxoplasmique. Program and abstracts of the 11th Interdisciplinary meeting on anti-infectious chemotherapy. Paris, France 5-6 December 1991, abstract n°170.
30. KATLAMA C., DEWIT S., GUICHARD A., VAN POTTELSBERHE C., VAN GLABEKE M., CLUMECK N., and the ENTA study group - A randomized european trial, comparing pyrimethamine-sulfadiazine (P/S) in AIDS toxoplasmic encephalitis (TE). Program and abstracts of mthe 32nd intersience conference on animicrobial agents and chemotherapy, American Society for Microbiology, California, 1992, abstract n°1215.
31. LEPORT C., AMBROISE-THOMAS P., CHENE G., DEROUIN F., KATLAMA C., RAFFI F., VILDE J.-L. - Place du cotrimoxazole dans la prophylaxie primaire de la toxoplasmose chez les patients infectés par le VIH. Méd Mal Infect. 1994; 24: 858-60.
32. GIRARD P.M., LANDMAN R., GAUDEBOUT C. et coll. - Dapsonepyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med. 1993; 328: 1514-20.